校友HW對此發出質疑：哥們說說哪個科學方式打的比較好？老肖整了10多年的反射弧，病例數足夠你老兄用統計分析了，方舟子打假不科學，咱用科學的方法給回擊就可以吧？最簡單的方式就是公開病例追蹤報告。可是除了那次老裘拍板的鑒定會，幾年過去了，還有新的報告沒有？要說可疑，肖同學拿10萬買殺手用鐵錘解決問題，那他的反射弧就更可疑了。shame on him。 另外另有學長拿他的手段和上次的王同學的情況比較很不妥。王同學就算有錯，也是走投無路所壓。肖同學是貪心不足也。
我們都有幸認識肖傳國大夫多年。他是一位受國際學術界尊敬的外科醫生和科學家，在恢複（脊椎損傷病人的）排尿和排便功能的神經再生研究中，他取得了重大進展。肖傳國醫生在美國完成了開創性的動物實驗研究，闡明支配大腿的運動神經可以用來繞接支配膀胱和排便。這個繞接可以形成一個反射作用（反射弧）來啟動來膀胱功能。他研究的成果已經多次發表在同行評議的國際科學期刊上。其他的科學家也已經重複並證實了肖醫生的這些研究結果。 肖醫生最終鼓起勇氣將動物實驗研究的成果轉化到臨床試驗上，在中國的脊柱損傷和脊柱裂病人身上開展神經繞接（神經通路重建，即反射弧）手術。在中國，由於缺乏抗痙攣藥物antimuscarinics和間歇性導尿術（自插導尿管），神經性膀胱功能障礙成為一種威脅生命的疾病。能緩解神經性膀胱功能障礙的並發症的療法，就是一種能夠拯救生命的成功。神經性膀胱和排大便功能障礙患者的病情是很痛苦的，包括遭受尿瀦留、尿失禁、反複感染、腎功能不全、大便失禁、便秘等，生活質量極差。神經通路重建手術是一個非常複雜的手術，需要神經的再生。不應當把手術的成功定義為完全恢複排便排尿功能。這項手術的重點在於收益超過風險。 肖醫生的臨床研究成果發表在多種學術刊物上，並兩次獲得Jack Lapides佳作獎，這是獎勵在神經泌尿科學界作出重要貢獻的科學家的最崇高的國際性大獎之一。2008年，因為他的科學成就，肖醫生還獲得了國際兒童排尿節製學會頒發的Kelm Hjalmas演講者（受邀做大會主題發言）榮譽。我們當中的許多人都曾經到中國去檢視肖醫生治療過的患者的情況，觀摩或者學習他發明的神經通路重建手術。肖醫生是一位非常有經驗的外科醫生，他對患者熱情照顧，不知疲倦地培訓來自世界各地的醫生們，來推廣他的神經通路重建手術。 在美國，已經開展過一項獨立而且嚴格的先期試驗來檢驗這項手術的安全性和效益。術後一年的治療結果最近發表在《泌尿科學雜誌》（Journal of Urology）上。在12個月的隨訪期間，在9位脊髓裂患者中，有7位患者，觀察到皮下至膀胱的神經反射弧的構建成立，證明神經通路重建手術的確起了作用。這個成績是了不起的，肖醫生應該得到嘉獎。並且，一部分患者已經展現出大小便排便功能的改善，並將隨時間推移而變得更好。術後36個月的成果正在分析中，不久就會發表。該先期試驗的數據是支持“肖氏手術”的，現在受NIH（美國國立衛生研究院）資助的臨床試驗正在開展，以進一步在脊髓裂患者中研究腰椎至骶神經通路重建。還有，在肖醫生的幫助和指導下，類似的臨床試驗也在世界範圍內開展。 中國人民和政府應該為肖醫生對病人所作出的貢獻、對他的科學成就，和他在世界上培訓醫生以推廣這項手術的誠意而自豪。國際科學界對肖醫生被拘捕的消息感到震驚。我們這些了解肖醫生的人，都對他涉入此案感到難以置信。 肖醫生是一個極富同情心的紳士，他的誠實和對本學科作出的開創性的科學成就廣受世界同行的尊敬。我們懇請中國政府和有關權威機構公正對待肖大夫，並在案情調查期間保障他的基本人權。在此事件中，請重視肖大夫對世界所作出的科學和人道主義事業的貢獻。
謹致
附：英文原件
September 29, 2010
To all:
We have all had the pleasure of knowing Dr. Chuan-Guo Xiao for many years. He is an internationally respected surgeon-scientist who has made major advances in the development of neuroregeneration to restore voiding and bowel function. Dr. Xiao performed groundbreaking animal research in the United States, demonstrating that a motor nerve that innervates the leg can be used to reinnervate the bladder and bowel. This reinnervation allows for development of a reflex to initiate bladder function. The results of his studies were published in peer-reviewed journals and other scientists have replicated Xiao’s findings confirming these results. Dr. Xiao eventually took the courageous step of moving from animal research to human studies and began performing the rerouting procedure on patients with spinal cord injury and spina bifida in China. Neurogenic bladder is life threatening in China due to a lack of both antimuscarinics and intermittent catheterization, and lessening the complications of neurogenic bladder would be considered a lifesaving success. Patients with neurogenic bladder and bowel suffer greatly and endure a host of issues such as urinary retention, incontinence, recurrent infections, renal insufficiency, fecal incontinence, constipation, and poor quality of life. For a procedure as complicated as nerve rerouting requiring nerve regeneration, one cannot expect normalization of bladder and bowel function to be the definition of success. What is important is that the benefits outweigh the risks of the procedure. Dr. Xiao published his clinical results in peer-reviewed journals and was twice honored by the Jack Lapides Essay Contest, one of the most respected international awards given to scientists who make major contributions to the field of neurourology. In 2008, he was named the Kelm Hjalmas Memorial Lecturer from the International Children’s Continence Society for his scientific achievements. Many of us have traveled to China to examine patients treated by Dr. Xiao and/or have been trained by him in the nerve rerouting surgery he invented. Dr. Xiao is a very skilled surgeon who is passionate about patient care and works tirelessly to train physicians around the world in performing his nerve rerouting procedure. In the United States, an independent and very rigorous pilot research trial was performed to test the safety and efficacy of this procedure. The one-year results were recently published in the Journal of Urology. At the 12-month follow-up visit, a cutaneous to bladder reflex was found in 7 of 9 spina bifida patients, confirming that rerouting does occur. This finding by itself is remarkable and Dr. Xiao should be commended. In addition, a number of patients demonstrated improvement in bladder and bowel function, which has continued to improve with longer patient follow-up. The 36-month results are currently being analyzed and will be reported in the near future. The pilot data was supportive of Dr. Xiao’s procedure, and now an NIH sponsored clinical trial is being conducted to further study lumbar to sacral nerve rerouting in spina bifida patients. In addition, similar procedures have been done worldwide, with Dr. Xiao helping to mentor the surgeons at each site. The Chinese people and government should be proud of Dr. Xiao for his dedication to his patients, his scientific achievements, and his willingness to train doctors around the world how to perform his surgery. The International scientific community was shocked to hear of Dr. Xiao’s arrest. Those of us who know Dr. Xiao well find it difficult to believe that he is involved in these attacks. Dr. Xiao is a compassionate man who is respected worldwide for his integrity and his innovative scientific contributions to society. We implore the Chinese government and authorities to treat Dr. Xiao fairly and to protect his human rights as these charges are investigated. Please strongly consider Dr. Xiao’s scientific and humanitarian contributions to the world as facts are gathered in this case.
Sincerely,
Kenneth M. Peters, MD, Professor and Chairman of Urology, Beaumont Hospital, Royal Oak, Michigan（美國Beaumont醫院泌尿科主任）
Jack S. Elder, M.D., Chief of Urology, Henry Ford Health System, Associate Director, Vattikuti Urology Institute, Department of Urology, Children's Hospital of Michigan, Clinical Professor of Urology, Case School of Medicine(美國密西根兒童醫院泌尿科主任)
Edwin A. Smith M.D., Assistant Clinical Professor of Urology, Emory University School of Medicine, Atlanta, Georgia（美國艾默裏大學醫學院臨床助理教授）
Kevin M. Feber, MD, FAAP, Board Certified in Pediatric Urology, Comprehensive Urology, William Beaumont Children's Hospital,（美國William Beaumont兒童醫院醫生）
Ananias C. Diokno, M.D., F.A.C.S.Executive Vice President & CMOBeaumont HospitalRoyal Oak, Michigan 48073 USA（美國Beaumont醫院執行副總裁）
Juan José de Benito, Urologist, Hospital Nacional de Clínicas, Córdoba, Argentina.（阿根廷國立醫院）
William E. Nantau B.Sc., CNIMClinical ManagerClinical Neurophysiology DepartmentBeaumont Hospital Royal Oak（美國Beaumont醫院臨床神經生理科臨床主管）
Evan J Kass MD,FACS,FAAPChief, Division of Pediatric UrologyBeaumont Childrens HospitalProfessor of Urology, Oakland University-William Beaumont School of Medicine（美國Beaumont兒童醫院泌尿科主任，奧克蘭大學醫學院教授）
Jacques Corcos MD.Professor of Urology, McGill UniversityGeneral Secretary of the International Continence SocietyJewish General hospital3755 Cote Ste-CatherineMontreal, Quebec, Canada H3T 1E2（加拿大麥基爾大學泌尿學教授，國際兒童排尿節製學會秘書長）
Jose Gonzalez, M.D., Department of Urology, Beaumont Hospital, Royal Oak, Michigan（美國Beaumont醫院泌尿科醫生）
Christopher Payne, MD, Associate Professor of Urology, Stanford University Medical School, Stanford, CA 94305-5118（美國斯坦福大學醫學院泌尿學副教授）
Kenneth I. Glassberg, MD, Director, Division of Pediatric Urology, Morgan Stanley Children's Hospital of New York-Presbyterian, Professor of Urology, Columbia University, College of Physicians and Surgeons, 3959 Broadway, CHN 1118（美國哥倫比亞大學醫學院泌尿學教授，兒童泌尿學分科主任）
Earl Y. Cheng, MD, Associate Professor of Urology, Children’s Memorial Hospital, Chicago, Illinois（美國芝加哥兒童醫院泌尿學副教授）
Darius J. Bagli, MDCM, Professor of Surgery, Senior Associate Scientist, Director of Urology Research, Divisions of Urology and Developmental & Stem Cell Biology, The Hospital For Sick Children, Institute of Medical Science, University of Toronto（加拿大多倫多大學外科學教授，泌尿學研究主任）
Henri B. LOTTMANN, MD, FEBU, FEBPS, FRCS(england) FEBPU, Paediatric urology unit, Hopital Necker-Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France（法國Necker-Enfants-Malades醫院兒童泌尿科醫生）
Dr. Amrish Vaidya MS. MCh.Consultant Paediatric Surgeon,Kokilaben Dhirubhai Ambani Hospital,4 Bungalows, Andheri W, Mumbai, India, （印度Kokilaben Dhirubhai Ambani醫院醫生）
Marc Cendron, MD, Associate Professor in Urology, Harvard Medical School, Children’s Hospital Boston, Boston, MA（美國哈佛大學醫學院泌尿學副教授）
Stuart B. Bauer, MD, Associate Director, Neurourology, Professor of Urology, Harvard Medical School, Children’s Hospital Boston, Boston, MA（美國哈佛大學醫學院泌尿學教授，波士頓兒童醫院神經泌尿科副主任）
Edmond T. Gonzales, Jr., MD, Professor of Urology, Baylor College of Medicine, （美國貝勒醫學院泌尿學教授）
Richard Macchia, MD FACS, SUNY Distinguished Teaching Professor, Cleveland Clinic, Florida（美國Cleveland臨床中心教授）
Benjamin Girdler, MD, Urology Center of the Rockies, Fort Collins, Colorado, （美國科羅拉多洛基泌尿中心醫生）
William C. de Groat, Ph.D., Professor of Pharmacology, University of Pittsburgh, （美國匹茲堡大學藥理學教授）
Michael R. Ruggieri, Sr., Ph.D., Director of Urologic Research, Temple University School of Medicine（美國坦普大學醫學院泌尿學研究主任）
Stanley J Kogan MDChief, Pediatric UrologyChildren's Hospital at MontefioreBronx NY USA（美國Montefiore兒童醫院兒童泌尿科主任）
Anthony Caldamone, MD, University Urologic Associates, Inc.2 Dudley St Ste 185Providence, RI 02905（美國布朗大學泌尿學中心醫生）
Yves Homsy MD, FRCSC, FAAP Clinical Professor of Urological Surgery and Pediatrics University of South Florida Children's Urology Group 5507 E. Longboat Blvd Tampa FL 33615（美國南弗羅裏達大學臨床泌尿學教授）
Dr. Enrique Turina, Professor of urology of the National University of Buenos Aires, Chief of section Urology of Instituto de Rehabilitación, Government of Buenos Aires, Argentina（阿根廷國立Buenos Aires大學泌尿學教授）
Dr. Angel Ozón, Urologist of the Instituto de Rehabilitación of Buenos Aires（阿根廷國立Buenos Aires大學泌尿學醫生）
Dr. Daniel Ekizian, Urologist of Instituto de Rehabilitación（阿根廷國立Buenos Aires大學泌尿學醫生）
Professor Dr. med. Karl-Dietrich Sievert, Vice Chair Prof. of Urology, Director - Uro-oncology, Neurourology, Incontinence, & Reconstructive Urology Department of Urology University of Tuebingen D72076 Tuebingen, Germany（德國Tuebingen大學泌尿學教授、主任）
Holly Gilmer, MD, Chief of Pediatric Neurosurgery, Beaumont Hospital, Royal Oak, Michigan（美國Beaumont醫院兒童神經外科主任）
Yegappan Lakshmanan, MD, Chief, Pediatric Urology, Children’s Hospital of Michigan（美國密西根兒童醫院兒童泌尿科主任）
回複TNEGI//ETNI的評論:
Fang ZhouZi did not make up something. He did not try to set someone up. What he said about Xiao' surgery is kind of true. I would not accept someone meant to make some number does not exist. Fang never said his surgery has no effect at all. He said all those 300 hundreds people he know did not get improved at all after surgery and and the total number given by Xiao is about 2000 surgeries.
回複ingodwetrustforever的評論:
I have no reason to say something I did not read. I am sorry that I can not do what noname8888 did to get the link. I read that about 2 or 3 months ago. You can find something interesting there by yourself if you really want to know the truth.
信口開河之前，麻煩作者先讀讀Journal of Urology上關於的肖傳國的理論和手術法的文章。
http://www.sciencedirect.com/science/article/pii/S0022534710030533
您隻要稍微懂點英語，就會知道，The results is ambiguous and seriously questioned in the Journal of Urology. (引自Nature News： http://www.nature.com/news/2010/100929/full/467511a.html)
校友HW對此發出質疑：哥們說說哪個科學方式打的比較好？老肖整了10多年的反射弧，病例數足夠你老兄用統計分析了，方舟子打假不科學，咱用科學的方法給回擊就可以吧？最簡單的方式就是公開病例追蹤報告。可是除了那次老裘拍板的鑒定會，幾年過去了，還有新的報告沒有？要說可疑，肖同學拿10萬買殺手用鐵錘解決問題，那他的反射弧就更可疑了。shame on him。 另外另有學長拿他的手段和上次的王同學的情況比較很不妥。王同學就算有錯，也是走投無路所壓。肖同學是貪心不足也。
我們都有幸認識肖傳國大夫多年。他是一位受國際學術界尊敬的外科醫生和科學家，在恢複（脊椎損傷病人的）排尿和排便功能的神經再生研究中，他取得了重大進展。肖傳國醫生在美國完成了開創性的動物實驗研究，闡明支配大腿的運動神經可以用來繞接支配膀胱和排便。這個繞接可以形成一個反射作用（反射弧）來啟動來膀胱功能。他研究的成果已經多次發表在同行評議的國際科學期刊上。其他的科學家也已經重複並證實了肖醫生的這些研究結果。 肖醫生最終鼓起勇氣將動物實驗研究的成果轉化到臨床試驗上，在中國的脊柱損傷和脊柱裂病人身上開展神經繞接（神經通路重建，即反射弧）手術。在中國，由於缺乏抗痙攣藥物antimuscarinics和間歇性導尿術（自插導尿管），神經性膀胱功能障礙成為一種威脅生命的疾病。能緩解神經性膀胱功能障礙的並發症的療法，就是一種能夠拯救生命的成功。神經性膀胱和排大便功能障礙患者的病情是很痛苦的，包括遭受尿瀦留、尿失禁、反複感染、腎功能不全、大便失禁、便秘等，生活質量極差。神經通路重建手術是一個非常複雜的手術，需要神經的再生。不應當把手術的成功定義為完全恢複排便排尿功能。這項手術的重點在於收益超過風險。 肖醫生的臨床研究成果發表在多種學術刊物上，並兩次獲得Jack Lapides佳作獎，這是獎勵在神經泌尿科學界作出重要貢獻的科學家的最崇高的國際性大獎之一。2008年，因為他的科學成就，肖醫生還獲得了國際兒童排尿節製學會頒發的Kelm Hjalmas演講者（受邀做大會主題發言）榮譽。我們當中的許多人都曾經到中國去檢視肖醫生治療過的患者的情況，觀摩或者學習他發明的神經通路重建手術。肖醫生是一位非常有經驗的外科醫生，他對患者熱情照顧，不知疲倦地培訓來自世界各地的醫生們，來推廣他的神經通路重建手術。 在美國，已經開展過一項獨立而且嚴格的先期試驗來檢驗這項手術的安全性和效益。術後一年的治療結果最近發表在《泌尿科學雜誌》（Journal of Urology）上。在12個月的隨訪期間，在9位脊髓裂患者中，有7位患者，觀察到皮下至膀胱的神經反射弧的構建成立，證明神經通路重建手術的確起了作用。這個成績是了不起的，肖醫生應該得到嘉獎。並且，一部分患者已經展現出大小便排便功能的改善，並將隨時間推移而變得更好。術後36個月的成果正在分析中，不久就會發表。該先期試驗的數據是支持“肖氏手術”的，現在受NIH（美國國立衛生研究院）資助的臨床試驗正在開展，以進一步在脊髓裂患者中研究腰椎至骶神經通路重建。還有，在肖醫生的幫助和指導下，類似的臨床試驗也在世界範圍內開展。 中國人民和政府應該為肖醫生對病人所作出的貢獻、對他的科學成就，和他在世界上培訓醫生以推廣這項手術的誠意而自豪。國際科學界對肖醫生被拘捕的消息感到震驚。我們這些了解肖醫生的人，都對他涉入此案感到難以置信。 肖醫生是一個極富同情心的紳士，他的誠實和對本學科作出的開創性的科學成就廣受世界同行的尊敬。我們懇請中國政府和有關權威機構公正對待肖大夫，並在案情調查期間保障他的基本人權。在此事件中，請重視肖大夫對世界所作出的科學和人道主義事業的貢獻。
謹致
附：英文原件
September 29, 2010
To all:
We have all had the pleasure of knowing Dr. Chuan-Guo Xiao for many years. He is an internationally respected surgeon-scientist who has made major advances in the development of neuroregeneration to restore voiding and bowel function. Dr. Xiao performed groundbreaking animal research in the United States, demonstrating that a motor nerve that innervates the leg can be used to reinnervate the bladder and bowel. This reinnervation allows for development of a reflex to initiate bladder function. The results of his studies were published in peer-reviewed journals and other scientists have replicated Xiao’s findings confirming these results. Dr. Xiao eventually took the courageous step of moving from animal research to human studies and began performing the rerouting procedure on patients with spinal cord injury and spina bifida in China. Neurogenic bladder is life threatening in China due to a lack of both antimuscarinics and intermittent catheterization, and lessening the complications of neurogenic bladder would be considered a lifesaving success. Patients with neurogenic bladder and bowel suffer greatly and endure a host of issues such as urinary retention, incontinence, recurrent infections, renal insufficiency, fecal incontinence, constipation, and poor quality of life. For a procedure as complicated as nerve rerouting requiring nerve regeneration, one cannot expect normalization of bladder and bowel function to be the definition of success. What is important is that the benefits outweigh the risks of the procedure. Dr. Xiao published his clinical results in peer-reviewed journals and was twice honored by the Jack Lapides Essay Contest, one of the most respected international awards given to scientists who make major contributions to the field of neurourology. In 2008, he was named the Kelm Hjalmas Memorial Lecturer from the International Children’s Continence Society for his scientific achievements. Many of us have traveled to China to examine patients treated by Dr. Xiao and/or have been trained by him in the nerve rerouting surgery he invented. Dr. Xiao is a very skilled surgeon who is passionate about patient care and works tirelessly to train physicians around the world in performing his nerve rerouting procedure. In the United States, an independent and very rigorous pilot research trial was performed to test the safety and efficacy of this procedure. The one-year results were recently published in the Journal of Urology. At the 12-month follow-up visit, a cutaneous to bladder reflex was found in 7 of 9 spina bifida patients, confirming that rerouting does occur. This finding by itself is remarkable and Dr. Xiao should be commended. In addition, a number of patients demonstrated improvement in bladder and bowel function, which has continued to improve with longer patient follow-up. The 36-month results are currently being analyzed and will be reported in the near future. The pilot data was supportive of Dr. Xiao’s procedure, and now an NIH sponsored clinical trial is being conducted to further study lumbar to sacral nerve rerouting in spina bifida patients. In addition, similar procedures have been done worldwide, with Dr. Xiao helping to mentor the surgeons at each site. The Chinese people and government should be proud of Dr. Xiao for his dedication to his patients, his scientific achievements, and his willingness to train doctors around the world how to perform his surgery. The International scientific community was shocked to hear of Dr. Xiao’s arrest. Those of us who know Dr. Xiao well find it difficult to believe that he is involved in these attacks. Dr. Xiao is a compassionate man who is respected worldwide for his integrity and his innovative scientific contributions to society. We implore the Chinese government and authorities to treat Dr. Xiao fairly and to protect his human rights as these charges are investigated. Please strongly consider Dr. Xiao’s scientific and humanitarian contributions to the world as facts are gathered in this case.
Sincerely,
Kenneth M. Peters, MD, Professor and Chairman of Urology, Beaumont Hospital, Royal Oak, Michigan（美國Beaumont醫院泌尿科主任）
Jack S. Elder, M.D., Chief of Urology, Henry Ford Health System, Associate Director, Vattikuti Urology Institute, Department of Urology, Children's Hospital of Michigan, Clinical Professor of Urology, Case School of Medicine(美國密西根兒童醫院泌尿科主任)
Edwin A. Smith M.D., Assistant Clinical Professor of Urology, Emory University School of Medicine, Atlanta, Georgia（美國艾默裏大學醫學院臨床助理教授）
Kevin M. Feber, MD, FAAP, Board Certified in Pediatric Urology, Comprehensive Urology, William Beaumont Children's Hospital,（美國William Beaumont兒童醫院醫生）
Ananias C. Diokno, M.D., F.A.C.S.Executive Vice President & CMOBeaumont HospitalRoyal Oak, Michigan 48073 USA（美國Beaumont醫院執行副總裁）
Juan José de Benito, Urologist, Hospital Nacional de Clínicas, Córdoba, Argentina.（阿根廷國立醫院）
William E. Nantau B.Sc., CNIMClinical ManagerClinical Neurophysiology DepartmentBeaumont Hospital Royal Oak（美國Beaumont醫院臨床神經生理科臨床主管）
Evan J Kass MD,FACS,FAAPChief, Division of Pediatric UrologyBeaumont Childrens HospitalProfessor of Urology, Oakland University-William Beaumont School of Medicine（美國Beaumont兒童醫院泌尿科主任，奧克蘭大學醫學院教授）
Jacques Corcos MD.Professor of Urology, McGill UniversityGeneral Secretary of the International Continence SocietyJewish General hospital3755 Cote Ste-CatherineMontreal, Quebec, Canada H3T 1E2（加拿大麥基爾大學泌尿學教授，國際兒童排尿節製學會秘書長）
Jose Gonzalez, M.D., Department of Urology, Beaumont Hospital, Royal Oak, Michigan（美國Beaumont醫院泌尿科醫生）
Christopher Payne, MD, Associate Professor of Urology, Stanford University Medical School, Stanford, CA 94305-5118（美國斯坦福大學醫學院泌尿學副教授）
Kenneth I. Glassberg, MD, Director, Division of Pediatric Urology, Morgan Stanley Children's Hospital of New York-Presbyterian, Professor of Urology, Columbia University, College of Physicians and Surgeons, 3959 Broadway, CHN 1118（美國哥倫比亞大學醫學院泌尿學教授，兒童泌尿學分科主任）
Earl Y. Cheng, MD, Associate Professor of Urology, Children’s Memorial Hospital, Chicago, Illinois（美國芝加哥兒童醫院泌尿學副教授）
Darius J. Bagli, MDCM, Professor of Surgery, Senior Associate Scientist, Director of Urology Research, Divisions of Urology and Developmental & Stem Cell Biology, The Hospital For Sick Children, Institute of Medical Science, University of Toronto（加拿大多倫多大學外科學教授，泌尿學研究主任）
Henri B. LOTTMANN, MD, FEBU, FEBPS, FRCS(england) FEBPU, Paediatric urology unit, Hopital Necker-Enfants-Malades, 149, rue de Sèvres, 75015 Paris, France（法國Necker-Enfants-Malades醫院兒童泌尿科醫生）
Dr. Amrish Vaidya MS. MCh.Consultant Paediatric Surgeon,Kokilaben Dhirubhai Ambani Hospital,4 Bungalows, Andheri W, Mumbai, India, （印度Kokilaben Dhirubhai Ambani醫院醫生）
Marc Cendron, MD, Associate Professor in Urology, Harvard Medical School, Children’s Hospital Boston, Boston, MA（美國哈佛大學醫學院泌尿學副教授）
Stuart B. Bauer, MD, Associate Director, Neurourology, Professor of Urology, Harvard Medical School, Children’s Hospital Boston, Boston, MA（美國哈佛大學醫學院泌尿學教授，波士頓兒童醫院神經泌尿科副主任）
Edmond T. Gonzales, Jr., MD, Professor of Urology, Baylor College of Medicine, （美國貝勒醫學院泌尿學教授）
Richard Macchia, MD FACS, SUNY Distinguished Teaching Professor, Cleveland Clinic, Florida（美國Cleveland臨床中心教授）
Benjamin Girdler, MD, Urology Center of the Rockies, Fort Collins, Colorado, （美國科羅拉多洛基泌尿中心醫生）
William C. de Groat, Ph.D., Professor of Pharmacology, University of Pittsburgh, （美國匹茲堡大學藥理學教授）
Michael R. Ruggieri, Sr., Ph.D., Director of Urologic Research, Temple University School of Medicine（美國坦普大學醫學院泌尿學研究主任）
Stanley J Kogan MDChief, Pediatric UrologyChildren's Hospital at MontefioreBronx NY USA（美國Montefiore兒童醫院兒童泌尿科主任）
Anthony Caldamone, MD, University Urologic Associates, Inc.2 Dudley St Ste 185Providence, RI 02905（美國布朗大學泌尿學中心醫生）
Yves Homsy MD, FRCSC, FAAP Clinical Professor of Urological Surgery and Pediatrics University of South Florida Children's Urology Group 5507 E. Longboat Blvd Tampa FL 33615（美國南弗羅裏達大學臨床泌尿學教授）
Dr. Enrique Turina, Professor of urology of the National University of Buenos Aires, Chief of section Urology of Instituto de Rehabilitación, Government of Buenos Aires, Argentina（阿根廷國立Buenos Aires大學泌尿學教授）
Dr. Angel Ozón, Urologist of the Instituto de Rehabilitación of Buenos Aires（阿根廷國立Buenos Aires大學泌尿學醫生）
Dr. Daniel Ekizian, Urologist of Instituto de Rehabilitación（阿根廷國立Buenos Aires大學泌尿學醫生）
Professor Dr. med. Karl-Dietrich Sievert, Vice Chair Prof. of Urology, Director - Uro-oncology, Neurourology, Incontinence, & Reconstructive Urology Department of Urology University of Tuebingen D72076 Tuebingen, Germany（德國Tuebingen大學泌尿學教授、主任）
Holly Gilmer, MD, Chief of Pediatric Neurosurgery, Beaumont Hospital, Royal Oak, Michigan（美國Beaumont醫院兒童神經外科主任）
Yegappan Lakshmanan, MD, Chief, Pediatric Urology, Children’s Hospital of Michigan（美國密西根兒童醫院兒童泌尿科主任）
